REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170 | +3.6% | 42,278 | +0.2% | 0.00% | +100.0% |
| Q2 2023 | $1,129 | +7.3% | 42,203 | -13.1% | 0.00% | 0.0% |
| Q1 2023 | $1,052 | -18.9% | 48,551 | -10.8% | 0.00% | -50.0% |
| Q4 2022 | $1,297 | -99.9% | 54,453 | +8.6% | 0.00% | +100.0% |
| Q3 2022 | $989,000 | +18.7% | 50,130 | +17.3% | 0.00% | 0.0% |
| Q2 2022 | $833,000 | -23.8% | 42,739 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,093,000 | +1.5% | 42,834 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $1,077,000 | -8.8% | 42,788 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,181,000 | -27.5% | 42,933 | -16.4% | 0.00% | -50.0% |
| Q2 2021 | $1,630,000 | +1.8% | 51,349 | +47.1% | 0.00% | 0.0% |
| Q1 2021 | $1,601,000 | +15.8% | 34,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,382,000 | +13.7% | 34,900 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $1,215,000 | +200.7% | 34,900 | +172.7% | 0.00% | 0.0% |
| Q2 2020 | $404,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |